Advertisements
Technology

What to know about Paxlovid

Or is it?

Let’s break down the large information.

First, at the moment’s announcement was vital. According to the drugmaker, its Phase 2/3 examine discovered that taking its new antiviral remedy lowered the danger of hospitalization or dying by 89% if taken inside three days of experiencing signs and 88% inside 5 days, versus the placebo.

Advertisements

This doesn’t imply you possibly can decide up Paxlovid at your native drug retailer simply but.

Pfizer mentioned this morning that it has shared its examine outcomes with the U.S. Food and Drug Administration as a part of its ongoing submission for what the trade calls emergency use authorization.

Paxlovid isn’t the one capsule of this type. In late November, an FDA advisory committee voted to suggest an emergency use authorization of Merck’s molnupiravir.

“This underscores the treatment candidate’s potential to save the lives of patients around the world,” Pfizer chairman and CEO Albert Bourla mentioned in a written assertion. “Emerging variants of concern, like Omicron, have exacerbated the need for accessible treatment options for those who contract the virus, and we are confident that, if authorized or approved, this potential treatment could be a critical tool to help quell the pandemic.”

Advertisements

The timeline from right here stays unclear. According to NBC News, the FDA has but to schedule an advisory committee assembly to evaluate the appliance. According to Pfizer, the complete information for the examine is anticipated to be launched someday this month and can be submitted for peer evaluate.

Show More

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button